You are here

Halaven

Eisai Pays up to $2B for ADC Bearing Its Halaven as Payload

BioSpace

Tue, 05/9/23 - 11:07 am

Bliss Biopharmaceutical

clinical trials

antibody-drug conjugate

Eisai latest cancer drugmaker to win UK approval after price cut

Yahoo/Reuters

Thu, 11/3/16 - 09:29 am

Eisai and Halozyme Sign Collaboration Agreement to Investigate Halaven® (Eribulin) and PEGPH20 in Metastatic Breast Cancer

Yahoo

Sat, 08/1/15 - 10:04 am

metastatic breast cancer

Auxilium recieves cautious assessment for Xiaflex, says Leerink

Yahoo/Fly on the Wall

Wed, 02/1/12 - 11:33 am

Dupuytren's Contracture